Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort.
Romberg-Camps M, Kuiper E, Schouten L, Kester A, Hesselink-van de Kruijs M, Limonard C, Bos R, Goedhard J, Hameeteman W, Wolters F, Russel M, Stockbrügger R, Dagnelie P. Romberg-Camps M, et al. Among authors: bos r. Inflamm Bowel Dis. 2010 Aug;16(8):1397-410. doi: 10.1002/ibd.21189. Inflamm Bowel Dis. 2010. PMID: 20027652
The role of inflow disease on patency of venous stents for post-thrombotic syndrome.
Bakas JM, de Wolf MAF, van den Bos RR, Malskat WSJ, van Montfrans C, van der Wilden GM, Verhagen HJM, van Rijn MJE. Bakas JM, et al. Among authors: van den bos rr. J Vasc Interv Radiol. 2024 Dec 9:S1051-0443(24)00754-1. doi: 10.1016/j.jvir.2024.11.030. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 39662620 Free article.
Induction of Cure in Early Arthritis (I CEA): study protocol for an investigator-initiated randomized single-blind clinical trial with open-label extension to compare three treatment strategies in patients with newly diagnosed undifferentiated arthritis.
Bergstra SA, van Ouwerkerk L, Nevins IS, van der Pol JA, Helmich GS, Hest I, van Veen A, Bos R, Goekoop-Ruiterman YPM, Vonkeman HE, Bijsterbosch J, de Jong PHP, Güler-Yüksel M, Böhringer S, Huizinga TWJ, van Gaalen FA. Bergstra SA, et al. Among authors: bos r. Trials. 2024 Nov 13;25(1):758. doi: 10.1186/s13063-024-08609-5. Trials. 2024. PMID: 39533416 Free PMC article.
Sleep disturbances in anorexia nervosa.
Burger P, Bos RW, Maas J, Simeunovic-Ostojic M, Gemke RJBJ. Burger P, et al. Among authors: bos rw. Eur Eat Disord Rev. 2024 Oct 23. doi: 10.1002/erv.3148. Online ahead of print. Eur Eat Disord Rev. 2024. PMID: 39444255 Review.
Growth and gut comfort of healthy term infants exclusively fed with a partially hydrolysed protein-based infant formula: a randomized controlled double-blind trial.
Kantaras P, Kokkinopoulou A, Hageman JHJ, Hassapidou M, Androutsos O, Kanaki M, Bovee-Oudenhoven I, Karaglani E, Kontochristopoulou AM, Bos R, Manios Y. Kantaras P, et al. Among authors: bos r. Front Pediatr. 2024 May 17;12:1328709. doi: 10.3389/fped.2024.1328709. eCollection 2024. Front Pediatr. 2024. PMID: 38827219 Free PMC article.
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs.
van de Laar CJ, Oude Voshaar MAH, Ten Klooster P, Tedjo DI, Bos R, Jansen T, Willemze A, Versteeg GA, Goekoop-Ruiterman YPM, Kroot EJ, van de Laar M. van de Laar CJ, et al. Among authors: bos r. RMD Open. 2024 May 30;10(2):e004291. doi: 10.1136/rmdopen-2024-004291. RMD Open. 2024. PMID: 38816210 Free PMC article. Clinical Trial.
710 results